X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TORRENT PHARMA FDC LTD./
TORRENT PHARMA
 
P/E (TTM) x 29.1 27.2 106.6% View Chart
P/BV x 6.1 5.2 116.9% View Chart
Dividend Yield % 0.8 1.1 74.3%  

Financials

 FDC LTD.   TORRENT PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TORRENT PHARMA
Mar-17
FDC LTD./
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,768 8.1%   
Low Rs791,186 6.7%   
Sales per share (Unadj.) Rs47.6346.1 13.7%  
Earnings per share (Unadj.) Rs7.655.2 13.8%  
Cash flow per share (Unadj.) Rs9.073.3 12.3%  
Dividends per share (Unadj.) Rs2.2514.00 16.1%  
Dividend yield (eoy) %2.00.9 213.3%  
Book value per share (Unadj.) Rs47.5257.1 18.5%  
Shares outstanding (eoy) m177.83169.22 105.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.34.3 54.8%   
Avg P/E ratio x14.626.8 54.6%  
P/CF ratio (eoy) x12.320.1 61.3%  
Price / Book Value ratio x2.35.7 40.7%  
Dividend payout %29.625.4 116.5%   
Avg Mkt Cap Rs m19,784249,887 7.9%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m1,2219,934 12.3%   
Avg. sales/employee Rs ThNM4,971.5-  
Avg. wages/employee Rs ThNM843.2-  
Avg. net profit/employee Rs ThNM792.4-  
INCOME DATA
Net Sales Rs m8,45958,569 14.4%  
Other income Rs m3942,233 17.6%   
Total revenues Rs m8,85260,802 14.6%   
Gross profit Rs m2,07013,773 15.0%  
Depreciation Rs m2493,069 8.1%   
Interest Rs m312,056 1.5%   
Profit before tax Rs m2,18410,881 20.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,545 39.2%   
Profit after tax Rs m1,3539,336 14.5%  
Gross profit margin %24.523.5 104.1%  
Effective tax rate %27.714.2 195.3%   
Net profit margin %16.015.9 100.4%  
BALANCE SHEET DATA
Current assets Rs m4,35553,841 8.1%   
Current liabilities Rs m1,79231,612 5.7%   
Net working cap to sales %30.338.0 79.8%  
Current ratio x2.41.7 142.7%  
Inventory Days Days4497 45.7%  
Debtors Days Days2584 29.4%  
Net fixed assets Rs m3,02542,079 7.2%   
Share capital Rs m179846 21.1%   
"Free" reserves Rs m8,24342,655 19.3%   
Net worth Rs m8,45343,501 19.4%   
Long term debt Rs m1122,408 0.0%   
Total assets Rs m10,557101,250 10.4%  
Interest coverage x71.46.3 1,134.8%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.80.6 138.5%   
Return on assets %13.111.3 116.5%  
Return on equity %16.021.5 74.6%  
Return on capital %23.519.6 119.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14620,066 5.7%   
Fx outflow Rs m3555,304 6.7%   
Net fx Rs m79114,762 5.4%   
CASH FLOW
From Operations Rs m1,48510,127 14.7%  
From Investments Rs m-620-7,869 7.9%  
From Financial Activity Rs m-753-1,918 39.2%  
Net Cashflow Rs m113212 53.3%  

Share Holding

Indian Promoters % 68.9 71.5 96.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 7.0 67.0%  
FIIs % 7.5 12.6 59.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 8.8 215.9%  
Shareholders   23,730 26,511 89.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 23, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS